What's new

Human medicines European public assessment report (EPAR): Pemetrexed Pfizer (previously Pemetrexed Hospira), pemetrexed, Date of authorisation: 19/11/2015, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Pemetrexed Pfizer (previously Pemetrexed Hospira), pemetrexed, Date of authorisation: 19/11/2015, Revision: 16, Status: Authorised

Apr 25, 2025 - 16:24
 0
Human medicines European public assessment report (EPAR): Pemetrexed Pfizer (previously Pemetrexed Hospira), pemetrexed, Date of authorisation: 19/11/2015, Revision: 16, Status: Authorised
Human medicines European public assessment report (EPAR): Pemetrexed Pfizer (previously Pemetrexed Hospira), pemetrexed, Date of authorisation: 19/11/2015, Revision: 16, Status: Authorised
Read More

Tags:

Previous Article

Akeso, Sino Biopharm’s Anniko enters crowded PD-1 market with FDA approval in he...

Next Article

A Night Where Purpose Meets Prestige: The Napa Valley Reserve Event on June 14, ...

Related Posts

European Shortages Monitoring Platform (ESMP): Implemen...

Mar 10, 2025  0

Development of a guideline on the quality aspects of mRNA vaccines - Scientific guideline

Development of a guideline on the quality aspects of mR...

Mar 31, 2025  0

Human medicines European public assessment report (EPAR): Brinavess, vernakalant hydrochloride, Date of authorisation: 01/09/2010, Revision: 18, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 7, 2025  0